Telcadiplus Tablets 80/12.5 mg

Adult dose

For patients whose blood pressure is not adequately controlled by telmisartan alone, take this medication once daily with or without food. It is recommended to adjust the doses of the individual components before switching to this fixed-dose combination. When clinically appropriate, direct switching from monotherapy to this combination may also be considered. - Telmisartan

Child dose

The safety and efficacy of this medication have not been established in children under 18 years of age.

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it may cause serious harm to the fetus. If pregnancy is confirmed, discontinue use immediately and consult a physician. This medication should not be administered to patients with specific allergies or severe impairment of liver and kidney function. Additionally, patients with bile duct obstruction or cholestasis should avoid taking this medication. Elderly patients or those with elevated potassium levels or impaired liver function should use this medication with caution. Care should also be taken in patients with heart or vascular diseases to prevent excessively low blood pressure. This medication may increase the risk of skin cancer, so sun exposure should be avoided and skin conditions should be checked regularly. Patients should carefully observe for side effects such as dizziness, low blood pressure, and electrolyte imbalances while taking this medication. Regular blood tests are needed due to the risk of potassium levels becoming too high or low. This medication may interact with other antihypertensive drugs, certain diuretics, lithium, and non-steroidal anti-inflammatory drugs, so it is essential to inform your physician of any other medications being taken. Caution should be exercised while driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as low blood pressure, electrolyte imbalances, and dehydration may appear, so immediate medical attention should be sought. Safety and efficacy have not been established for children under 18 years of age. This medication should be kept out of reach of children and not transferred to another container.

Serious side effects

Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in the oral/ocular mucosa, wheezing or difficulty breathing, asthma attack, respiratory irregularities with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizure, altered consciousness, visual disturbances,

Mild side effects

• Bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia
• sleep disturbances

This medication should be stored in a tightly sealed container to prevent air and moisture exposure, ideally at a temperature between 1 and 30 degrees Celsius. This helps to maintain the medication's effectiveness.

Appearance

White or off-white, oblong tablets

Package unit

30 tablets/bottle